Population Pharmacokinetics and Exposure-Response Relationships of Belimumab Following Subcutaneous Administration in Subjects with Systemic Lupus Erythematosus

被引：0
|
作者：
Struemper, Herbert [1 ]
Thapar, Mita [2 ]
Gordon, David [3 ]
Roth, David [3 ]
机构：
[1] PAREXEL, Quantitat Clin Dev, Durham, NC USA
[2] ICON, Marlow, Bucks, England
[3] GlaxoSmithKline, Collegeville, PA USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-17
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and Exposure-response of Intravenous Belimumab in Children with Systemic Lupus Erythematosus
    Dimelow, Richard
    Ji, Beulah
    Struemper, Herbert
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus
    Struemper, Herbert
    Chen, Cecil
    Cai, Wendy
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (07): : 711 - 720
  • [3] Inter-regional pharmacokinetics and exposure-response analyses of belimumab in patients with system lupus erythematosus
    Wu, Junyi
    Zhou, Xuan
    Dimelow, Richard
    Marshall, Scott
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [4] POPULATION PHARMACOKINETICS OF BELIMUMAB IN HEALTHY AMERICAN AND JAPANESE SUBJECTS FOLLOWING SUBCUTANEOUS ADMINISTRATION.
    Yapa, S. W. S.
    Struemper, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S86 - S86
  • [5] Subcutaneous belimumab in the treatment of systemic lupus erythematosus
    Elalouf, Ofir
    Keeling, Stephanie O.
    Touma, Zahi
    IMMUNOTHERAPY, 2018, 10 (13) : 1163 - 1173
  • [6] Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
    Dimelow, Richard
    Ji, Beulah
    Struemper, Herbert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (06): : 622 - 633
  • [7] Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine
    Ryuji Kubota
    Kazuya Fukumura
    Toshihiro Wajima
    Pharmaceutical Research, 2018, 35
  • [8] Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine
    Kubota, Ryuji
    Fukumura, Kazuya
    Wajima, Toshihiro
    PHARMACEUTICAL RESEARCH, 2018, 35 (11)
  • [9] Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration
    Poh, Y. J.
    Baptista, B.
    D'Cruz, David P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (10) : 925 - 938
  • [10] PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Sheikh, S. Z.
    Fox, N. L.
    Hammer, A. E.
    Struemper, H.
    Groark, J.
    Roth, D.
    Gordon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 297 - 298
12345